Early drug and anti-infliximab antibody levels for prediction of primary nonresponse to infliximab therapy.
about
Early drug and anti-infliximab antibody levels for prediction of primary nonresponse to infliximab therapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Early drug and anti-infliximab ...... esponse to infliximab therapy.
@en
Early drug and anti-infliximab ...... esponse to infliximab therapy.
@nl
type
label
Early drug and anti-infliximab ...... esponse to infliximab therapy.
@en
Early drug and anti-infliximab ...... esponse to infliximab therapy.
@nl
prefLabel
Early drug and anti-infliximab ...... esponse to infliximab therapy.
@en
Early drug and anti-infliximab ...... esponse to infliximab therapy.
@nl
P2093
P2860
P50
P356
P1476
Early drug and anti-infliximab ...... esponse to infliximab therapy.
@en
P2093
L Selinger
S Ben-Horin
P2860
P304
P356
10.1111/APT.14410
P407
P577
2017-11-09T00:00:00Z